These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6342843)

  • 1. Effect of propranolol in reducing mortality in older myocardial infarction patients. The Beta-Blocker Heart Attack Trial experience.
    Hawkins CM; Richardson DW; Vokonas PS
    Circulation; 1983 Jun; 67(6 Pt 2):I94-7. PubMed ID: 6342843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial.
    Goldstein S
    Circulation; 1983 Jun; 67(6 Pt 2):I53-7. PubMed ID: 6342840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Beta-blocker Heart Attack Trial.
    Furberg CD
    Z Kardiol; 1985; 74 Suppl 6():159-63. PubMed ID: 2869615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience.
    Furberg CD; Byington RP
    Circulation; 1983 Jun; 67(6 Pt 2):I98-101. PubMed ID: 6133654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients.
    Hansteen V
    Circulation; 1983 Jun; 67(6 Pt 2):I57-60. PubMed ID: 6342841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of propranolol on blood lipids and lipoproteins in myocardial infarction.
    Shulman RS; Herbert PN; Capone RJ; McClure D; Hawkins CM; Henderson LO; Saritelli A; Campbell J
    Circulation; 1983 Jun; 67(6 Pt 2):I19-21. PubMed ID: 6851036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Infarction Study (E.I.S.). A secondary prevention study with slow release oxprenolol after myocardial infarction: morbidity and mortality.
    Eur Heart J; 1984 Mar; 5(3):189-202. PubMed ID: 6373264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beta-blocker heart attack trial. beta-Blocker Heart Attack Study Group.
    JAMA; 1981 Nov; 246(18):2073-4. PubMed ID: 7026815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of elderly and younger patients with out-of-hospital chest pain. Clinical characteristics, acute myocardial infarction, therapy, and outcomes.
    Tresch DD; Brady WJ; Aufderheide TP; Lawrence SW; Williams KJ
    Arch Intern Med; 1996 May; 156(10):1089-93. PubMed ID: 8638996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of renal dysfunction in patients with chronic heart failure: 12-month follow-up.
    Roik M; Starczewska MH; Stawicki S; Solarska-Półchłopek A; Warszawik O; Oreziak A; Kochanowski J; Kosior D; Opolski G
    Kardiol Pol; 2006 Jul; 64(7):704-11; discussion 712. PubMed ID: 16886127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks.
    Liu L;
    Chin Med J (Engl); 2001 Feb; 114(2):115-8. PubMed ID: 11780187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of propranolol on mortality and morbidity after acute myocardial infarction.
    Abela GS; Mehta J; Conti CR
    J Fla Med Assoc; 1982 Jun; 69(6):453-7. PubMed ID: 7097220
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent trends in hospital mortality of acute myocardial infarction--the Worcester Heart Attack Study. Have improvements been realized for all age groups?
    Gurwitz JH; Goldberg RJ; Chen Z; Gore JM; Alpert JS
    Arch Intern Med; 1994 Oct; 154(19):2202-8. PubMed ID: 7944841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: the Beta-Blocker Heart Attack Trial experience.
    Byington RP; Worthy J; Craven T; Furberg CD
    Am J Cardiol; 1990 Jun; 65(20):1287-91. PubMed ID: 2188492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study.
    Ueshima K; Fukami K; Hiramori K; Hosoda S; Kishida H; Kato K; Fujita T; Tsutani K; Sakuma A;
    Am Heart J; 2004 Aug; 148(2):e8. PubMed ID: 15309011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Do beta-blockers prevent coronary events in hypertensive patients?].
    Diévart F; Ragot S; Julien J; Herpin D
    Arch Mal Coeur Vaiss; 2005 Sep; 98(9):881-8. PubMed ID: 16231574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary angioplasty in patients > or = 75 years old with ST-elevation myocardial infarction - one-year follow-up results.
    Ciszewski A; Karcz M; Kepka C; Bekta P; Ksiezycka E; Przyłuski J; Debski A; Witkowski A; Ruzyłło W
    Kardiol Pol; 2008 Aug; 66(8):828-33; discussion 834-6. PubMed ID: 18803134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
    JAMA; 1982 Mar; 247(12):1707-14. PubMed ID: 7038157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
    Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.